United States · FDA National Drug Code directory

Sulfasalazine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 11534-200_97b74888-4b28-4f9a-b5b9-64d23bc7e808
Product NDC: 11534-200
Form: TABLET
Composition / generic term: Sulfasalazine
Labeler: Sunrise Pharmaceutical, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20250715
Source listing expiry: 20261231

Source-listed ingredients

SULFASALAZINE — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (11534-200-01) · 11534-200-01
500 TABLET in 1 BOTTLE (11534-200-04) · 11534-200-04
300 TABLET in 1 BOTTLE (11534-200-07) · 11534-200-07

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →